Gilead Sciences

GILD NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $6,686,000 $7,115,000 $7,050,000 $6,599,000
Gross Profit 5,134,000 5,555,000 5,485,000 5,157,000
EBITDA 2,992,000 3,139,000 2,641,000 2,054,000
EBIT 2,302,000 2,455,000 2,623,000 1,665,000
Net Income -4,170,000 1,429,000 2,180,000 1,045,000
Net Change In Cash 6,686,000 7,115,000 7,050,000 6,599,000
Cost of Revenue 754,000
Free Cash Flow 2,114,000 1,954,000 1,634,000 2,198,000
Cash 4,718,000 6,085,000 5,705,000 5,704,000
Basic Shares 1,247,000 1,256,000 1,257,000 1,258,000

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $27,116,000 $27,281,000 $27,305,000 $24,689,000
Gross Profit 27,116,000 21,624,000 20,704,000 20,117,000
EBITDA 7,605,000 10,393,000 9,456,000 8,509,000
EBIT 7,605,000 7,330,000 7,406,000 7,029,000
Net Income 5,665,000 4,592,000 6,225,000 89,000
Net Change In Cash 27,116,000 27,281,000 27,305,000 24,689,000
Cost of Revenue 137,000 -624,000 -5,677,000
Free Cash Flow 7,421,000 8,344,000 10,805,000 7,518,000
Cash 6,085,000 5,412,000 5,338,000 5,997,000
Basic Shares 1,258,000 1,262,000 1,262,000 1,263,000

Earnings Calls

Quarter EPS
2024-03-31 -$1.32
2023-12-31 $1.72
2023-09-30 $2.29
2023-06-30 $1.66